Do patients with thalamic pain have a specific somatosensory phenotype? (P1.222)

Conclusions:The somatosensory phenotype of the CPSP patients was characterized by reduced sensation for vibration and light touch on the affected side. These patients showed mechanical hyperalgesia and more pronounced hypoesthesia, but no temperature perception abnormalities, compared to the control patients. Our results do not support the view that a specific dysfunction of the spinothalamic tract is involved in the pathogenesis of thalamic CPSP.Disclosure: Dr. Papadopoulou has nothing to disclose. Dr. Magon has nothing to disclose. Dr. Gaetano has received personal compensation for activities with Novartis Pharmaceuticals as an advisory board member. Dr. Jaeger has nothing to disclose. Dr. Kappos has reveived personal compensation for activities with University Hospital Basel as an advisory board member. Dr. Kappos has received research support from Swiss Multiple Sclerosis Society, Swiss National Research Foundation, European Union, Gianni Rubatto Foundation, Novartis Research Foundation, and Roche Research Foundation. Dr. Sprenger have received personal compensation for activities with Biogen Idec, Eli Lilly, Allergan, Actelion, ATI, Mitsubishi Pharma, Novartis, and Sanofi Genzyme. Dr. Sprenger received research support from Novartis Pharmaceuticals Switzerland, Swiss MS Society, and Swiss National Science Foundation.
Source: Neurology - Category: Neurology Authors: Tags: Pain and Palliative Care Source Type: research